A critical discovery in cancer research is emerging with the use of nanobodies to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in various types of cancer, causing https://seobookmarkpro.com/story21971771/mini-antibodies-revive-tumor-suppressor-p53-the-potential-approach-for-malignant-treatment